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ABSTRACT
Diamond–Blackfan anemia (DBA) is a rare congeni-
tal disease linked to mutations in the ribosomal
protein genes rps19, rps24 and rps17. It belongs to
the emerging class of ribosomal disorders. To
understand the impact of DBA mutations on
RPS19 function, we have solved the crystal struc-
ture of RPS19 from Pyrococcus abyssi. The protein
forms a five a-helix bundle organized around a
central amphipathic a-helix, which corresponds to
the DBA mutation hot spot. From the structure, we
classify DBA mutations relative to their respective
impact on protein folding (class I) or on surface
properties (class II). Class II mutations cluster into
two conserved basic patches. In vivo analysis in
yeast demonstrates an essential role for class II
residues in the incorporation into pre-40S ribosomal
particles. This data indicate that missense muta-
tions in DBA primarily affect the capacity of the
protein to be incorporated into pre-ribosomes, thus
blocking maturation of the pre-40S particles.
INTRODUCTION
Diamond–Blackfan anemia (DBA) is a rare congenital
disorder characterized by the defective diﬀerentiation of
pro-erythroblasts, the precursors of red blood cells.
Patients suﬀer severe anemia and display heterogeneous
clinical features including malformations, growth failure
and predisposition to cancer (1,2). Linkage analysis has
revealed that a quarter of all DBA reported cases are
connected to the heterozygous mutation of the gene
encoding the ribosomal protein RPS19 (3,4). The RPS19
protein is a component of the 40S ribosomal subunit and
belongs to a family of ribosomal proteins restricted to
eukaryotes and archea. It is essential for yeast viability
and for early stages of development in mice (5,6).
Disruption as well as point mutations of the rps19 gene
in yeast and human cells aﬀect maturation of the pre-
ribosomal RNA (pre-rRNA) and block production of the
40S ribosomal subunits (5,7–9). Why the mutation of
a ribosomal protein primarily aﬀects pro-erythroblast
diﬀerentiation remains a central question. However,
recent linkage of a two other ribosomal protein genes,
rps24 and rps17, to DBA (10,11) strongly supports the
hypothesis that DBA is the consequence of a ribosomal
disorder (8,12).
Over 60 diﬀerent mutations aﬀecting the rps19 gene
have been reported, including deletions, insertions, frame-
shifts, premature stop codons and missense mutations
(13–15). Some mutations, like very early stop codons or
modiﬁcation of the promoter clearly result in RPS19
haplodeﬁciency by hampering synthesis of RPS19 from
the mutated allele. However, for more subtle mutations
like missense mutations, the question arises as to
whether they aﬀect the folding of the protein or whether
they are milder mutations aﬀecting the function while
preserving the overall fold. Since there is no homolog of
RPS19 in bacteria, for which high-resolution structures
of the small ribosomal subunit are available, the structure
of RPS19 and its precise location within the 40S subunit
remain unknown. The crystal structure of RPS19
from Pyroccocus abyssi presented herein ﬁlls this gap
and provides a rationale for the impact of RPS19
mutations in DBA.
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Proteinexpression, purification and crystallization
Pyrococcus abyssi RPS19 cDNA was cloned into a
pET-15b (Novagen) modiﬁed plasmid. The expression
was carried out in BL21 (DE3) Rosetta cells (Novagen) at
158C. Bacterial cells were sonicated and centrifuged for
30min at 50 000g. The supernatant was heated up for
20min at 508C and centrifuged for another 30min at
50000g. After incubation and elution from the cobalt-
aﬃnity resin, the tag was cleaved from the protein by an
overnight digest with 1/200 (w/w) ratio with TEV. A step
of puriﬁcation on Hi-S (Pharmacia) was carried out and
the protein was eluted at about 600mM NaCl. The
protein was concentrated to up to 10mg/ml in 50mM
Tris–HCl pH 7.5, 600mM NaCl. Crystals were obtained
at 208C by the hanging drop vapor diﬀusion method by
mixing equal amounts of the protein solution and of a
reservoir composed of 30–36% PEG 2000 MME, 100mM
Tris–HCl pH 6.8–7.5 over a couple days to a size of
50 200 200 microns. They diﬀracted to 1.15A ˚ on
synchrotron beamline and belonged to the space group
P212121 with cell dimensions a¼32A ˚ , b¼57A ˚ , c¼82A ˚
and contained one molecule per asymmetric unit and 48%
solvent.
Structure solution and refinement
Native and derivative data were collected at the ESRF
synchrotron and processed with XDS (16). Data collection
statistics are shown in Table 1. A HgBr2 derivative
resulting from a 12-h soak in 2.5% (v/v) HgBr2 (prepared
from a saturated solution) was collected at the LIII-edge
of Hg. Derivative data set was combined with the most
isomorphous native data set, SHELXD and SHARP were
used to locate and reﬁne the heavy atom site position
(17,18). The resulting phases had an overall ﬁgure of merit
(FOM) of 0.33 at a resolution of 2.0A ˚ . After solvent
ﬂattening with Solomon (SHARP), automatic building
was carried out with ARP/wARP (19). Out of a total of
150 residues, 125 were initially placed. Further building
and reﬁnement cycles were carried out with Coot and
REFMAC (20,21). Last cycles of reﬁnement were carried
out including hydrogens and using individual anisotropic
B factors.
The ﬁnal model has a good stereochemistry with an
R-free value of 15.5% and a R-factor value of 13.7%
(Table 1).
Analysisof RPS19mutations in yeast
Site-directed mutagenesis on yeast RPS19 was performed
by PCR. For complementation experiments, the mutated
alleles were subcloned into vector pFL38-Ps15 (URA3),
downstream of the constitutive RPS15 promoter. The
resulting plasmids were introduced in the ura3
GAL-RPS19 strain (5). Cells were cultured in liquid
synthetic medium containing galactose, but no uracil, and
spotted at diﬀerent densities on agar plates using the same
medium, with either galactose or glucose as the carbon
source to modulate RPS19 expression.
To evaluate incorporation of wild-type or mutated
RPS19A into ribosomes, the corresponding open reading
frames were also cloned in frame downstream the TAP tag
coding sequence in the pFL38-Ps15 vector and expressed
in Euroscarf strain Y06271 (rps19A::KanMX, RPS19B).
Whole cell extracts were fractionated by ultracentrifuga-
tion on sucrose gradient for ribosome analysis. Two
hundred milliliters of yeast culture were grown in YPD
medium to an OD600 of 0.5 and cycloheximide was added
at a ﬁnal concentration of 100mg/ml. After 10min
incubation, yeast cells were harvested by centrifugation
at 5000 r.p.m and washed in 20ml ice-cold buﬀer
A [20mM HEPES (pH 7.5), 10mM KCl, 5mM MgCl2,
1mM EGTA, 1mM DTT and 100mg/ml cycloheximide].
Cells were broken with glass beads and re-suspended
in 150ml buﬀer A. The suspension was clariﬁed by
centrifugation for 5min at 10000 r.p.m. An amount of
the extract corresponding to 1mg of protein was loaded
on a 10.5ml 10–50% sucrose gradient in buﬀer A without
cycloheximide and centrifuged for 12h at 26 000 r.p.m in a
SW41 rotor. A gradient collector (A ¨ KTAprime—
Amersham Biosciences), in combination with a
Pharmacia UV-detector LKB.UV-M II, was used to
record the UV proﬁle. Twenty 0.5ml fractions were
collected and 150ml of each fraction were slot-blotted
on nitrocellulose membrane to detect TAP-tagged
RPS19A. The membrane was then incubated with
Table 1. Crystallographic data phasing and reﬁnement statistics
Native 1 Native 2 Hg derivative
Space group P212121 P212121 P212121
Cell dimensions
a, b, c (A ˚ ) 32.70, 57.43,
80.20
31.78, 57.78,
81.03
31.58, 57.39,
81.58
a, b, g (8) 90.0, 90.0,
90.0
90.0, 90.0,
90.0
90.0, 90.0,
90.0
X-ray source ID14-4 ID29 ID29
Wavelength (A ˚ ) 0.9840 1.0332 1.00932
Resolution (A ˚ ) 28–1.15 25–1.9 20–1.91
Total measurements 375444
(18387)
75962
(7898)
78175 (9427)
Unique reﬂections 49876
(5 511)
19967 (2147) 21251 (2664)
Redundancy 7.5 (3.3) 3.8 (3.7) 3.7 (3.5)
Completeness (%) 91.5 (72.3) 87.9 (66.0) 94.1 (82.6)
Rsym (%) 5.5 (21.2) 6.8 (29.1) 5.6 (15.7)
Riso 23.4 (26.0)
a
(Native 2 versus Hg derivative) (%)
I/ 22.25 (6.12) 14.01 (4.43) 15.48 (7.64)
FOM (acentric) 0.330
Reﬁnement statistics
Number of residues 140
Number of water
molecules
186
Number of ions 2
RMSD 
2 bonds (A ˚ ) 0.019
RMSD 
2 angles (8) 1.818
Rwork (%) 13.73
Rfree (%) 15.49
Statistics for high resolution bin (1.15–1.25A ˚ , 1.9–2.0A ˚ ) are indicated
in parentheses.
aHigh resolution bin (2.5–2.6A ˚ ) are indicated in parentheses.
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revealed by chemoluminescence (ECL, GE Healthcare).
After scanning of the ﬁlm to obtain a digital image,
the labeling intensity for each fraction was quantiﬁed
by densitometry using MetaMorph (Universal Imaging).
The UV proﬁles were superimposed with the blot
quantiﬁcations to obtain Figure 5.
Ribosomal RNAs were co-immunoprecipitated with
RPS19-TAP and analysed as published previously (22,23).
Pre-rRNAs were detected on northern blots with probe
D-A2 (50-GAAATCTCTCACCGTTTGGAATAGC-30)
and A2-A3 (50-ATGAAAACTCCACAGTG-30).
RESULTS AND DISCUSSION
Overall structure of RPS19
The structure of RPS19 from P. abyssi (RPS19
Pa) was
determined by SIRAS on a mercury derivative and reﬁned
against the best native data set. The ﬁnal model has an
R-free value of 15.5% (Table 1) and comprises residues
2 to 150 with the exception of two disordered loops
between residues 37–44 and 79–84 (Figure 1a). The
structure of RPS19 is almost entirely a-helical and folds
around a ﬁve a-helix bundle. Knowing that human RPS19
(RPS19
Hs) shares 36% identity and 57% similarity with
P. abyssi RPS19 (RPS19
Pa) sequence (Figure 1c), we may
assume that they display a similar fold. In the rest of
the text, RPS19 residues in P. abyssi, Saccharomyces
cerevisiae and Homo sapiens are labeled ‘Pa’, ‘Sc’ and ‘Hs’
respectively (Table 2).
Twodistinct classesof mutationsin DBA patients cluster
aroundan amphipathic helix
Fourteen amino acids of RPS19 are the targets of missense
mutations in DBA patients. Although these mutations
are spread along the entire primary sequence (Figure 1c),
the structure of RPS19
Pa shows that most missense
mutations cluster within or around the a-helix 3
(Figure 1a). This a-helix, made of residues 50–65 of
RPS19
Pa (52–67 in human numbering), corresponds to the
mutation hot spot. It is located at a central position in the
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Figure 1. RPS19 structure and sequence alignment. (a) Overall structure of RPS19 and point mutations found in DBA patients. Residues labeled in
green and red correspond to structural residues (class I) and to solvent accessible residues (class II), respectively. Green and red numbers correspond
to human numbering. Gray numbers correspond to P. abyssi numbering. Deletions encountered in DBA patients are shown in orange. Dashed lines
correspond to disordered loops in the structure. (b) The hot spot of mutations. Mutated residues found in and around the hot spot of mutation are
shown as in (a). (c) Sequence alignment of RPS19 orthologs. RPS19 ortholog sequences have been retrieved and aligned using PipeAlign program
suite (31). Class I (boxed in green) and class II (boxed in red) residues are displayed. Deletions encountered in DBA patients are show as orange
boxes. Secondary sequence elements are shown on top of the sequence.
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with a-helices 4 and 5 on the other side (Figure 1a).
The apolar side of a-helix 3 is engaged into hydrophobic
interactions with residues of the neighboring a-helices,
thus forming the hydrophobic core of the protein
(Figure 1b). Strikingly, three mutations on a-helix 3
(A57P
Hs, A61S/E
Hs, L64P
Hs), two on a-helix 1 (V15F
Hs
and L18P
Hs) and two on a-helix 6 (G127E
Hs and
L131R
Hs) aﬀect residues involved in this hydrophobic
core (green residues on Figure 1). Thus, although distant
on the primary sequence, these seven amino acids are
functionally related and are involved in the folding and
the stability of the protein.
In contrast, mutations P47L
Hs, W52R
Hs, R56Q
Hs,
S59F
Hs, R62W/Q
Hs, R101H
Hs and G120S
Hs aﬀect resi-
dues located on the surface of RPS19 (red residues on
Figure 1). Remarkably, these residues show a much higher
degree of inter-species conservation than the amino acids
within the hydrophobic core (Figure 1c). These residues
are located within two highly conserved basic patches
at the surface of the protein (Figure 2). On the polar face
of a-helix 3, four exposed mutated residues (W52
Hs,
R56
Hs, S59
Hs and R62
Hs) form the ﬂoor of a central basic
groove (patch A on Figure 2a–c). In addition, residues
from a-helices 4 and 5 and from the b-sheet deﬁne
the conserved patch B (Figure 2d–f). It comprises
residues R99
Pa (R101
Hs), K100
Pa (R102
Hs), Q103
Pa
(Q105
Hs), K113
Pa (K115
Hs), G118
Pa (G120
Hs) and
R119
Pa (R121
Hs). DBA mutations R101H
Hs and
G120S
Hs aﬀect this conserved surface. Interestingly, both
conserved surfaces have a positive electrostatic charge:
patch A harbors a localized positive charge (Figure 2c),
whereas patch B is embedded in a larger positive area
(Figure 2f).
Based on these observations, we propose to subdivide
DBA mutations into two classes: class I encompasses
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Figure 2. Inter-species conservation and electrostatic surface properties of RPS19. Panels a–c and panels d–f are presented under the same
orientation, respectively. (a) and (d) Ribbon diagrams of RPS19. (b) and (e) Surface residue conservation of RPS19. Surface conservation was
calculated based on the sequence alignment shown in Figure 1 and using ConSurf server with default parameters (32). Conservation is displayed
according to white (non-conserved) to purple (100% conservation). Conserved regions are circled in black. Numbering follows the same rule as in
Figure 1. (c) and (f) Electrostatic charge distribution on the surface of RPS19 was calculated using APBS program default parameters (33). Highly
conserved and charged areas are boxed.
Table 2. Amino acid correspondence in Human, yeast and P. abyssi
P, abyssi Yeast Human DBA mutation Class
V13 I15 V15 V15F I
V16 Y18 L18 L18P I
P45 P47 P47 P47L II
W50 W53 W52 W52R II
R54 R57 R56 R56Q II
V55 A58 A57 A57P I
S57 S60 S59 S59F II
L59 A62 A61 A61S/E I
R60 R63 R62 R62W/Q II
V62 I65 L64 L64P I
R99 R102 R101 R101H II
G118 G121 G120 G120S II
R119 R122 R120 -
G125 G128 G127 G127E I
S127 R130 R129 -
L129 L132 L131 L131R I
K131 R134 R133 -
5916 Nucleic Acids Research, 2007, Vol. 35, No. 17structural residues aﬀecting the folding of the protein;
class II mutations aﬀect surface residues and would impair
the function of RPS19 without altering its overall fold.
It should be noted that the Val13
Pa (V15F
Hs) and W50
Pa
(W52R
Hs) are partially involved in Van der Waals
contacts with neighboring atoms and are also partially
exposed to the solvent. Class I mutations aﬀecting protein
folding are predicted to render the protein unstable.
Indeed, when expressed in COS cells, mutant RPS19
V15F
Hs and G127E
Hs were shown to be present at low
level, in contrast to class II mutants R56Q
Hs, R62W
Hs
whose level was similar to that of wild-type RPS19 (24,25).
Along this line, a recent report conﬁrms and extends
these results by showing that class I mutants V15F
Hs,
L18P
Hs, A57P
Hs, A61S/E
Hs, G127E
Hs and L131P
Hs are
rapidly degraded by the proteasome when expressed in
mammalian cells, whereas class II mutants P47L
Hs,
W52R
Hs, R56Q
Hs, R62W
Hs, R62Q
Hs, R101H
Hs, are
G120S
Hs are more stable (26). Thus, the classiﬁcation
proposed here perfectly correlates with the instability
observed for class I mutants expressed in cultured cells.
The conserved basic patches arecritical for RPS19function
In order to test whether the conserved surface areas are
essential for the function RPS19, we performed functional
complementation in yeast. RPS19 is encoded by two
genes, RPS19A and RPS19B, in S. cerevisiae. DBA-like
mutations, as well as systematic R to E mutations that
alter the charge of these basic conserved areas, were
introduced by site-directed mutagenesis into the RPS19A
gene. The ability of these mutant alleles to support growth
was evaluated in a rps19A rps19B mutant strain
conditionally expressing the wild-type RPS19A under
control of a galactose promoter. As shown in Figure 3,
DBA mutations R57Q
Sc, R63Q
Sc and R102H
Sc had
a drastic eﬀect on RPS19 capacity to support cell
growth in glucose, whereas mutation R63W
Sc partially
supported growth. Similarly, mutation to glutamic acid of
R57
Sc, S60
Sc and R63
Sc in patch A and R102
Sc, R122
Sc in
patch B, completely abolished cell growth. In contrast, the
double mutation R130E-R134E, outside of the conserved
patches, had little impact on viability. These results show
the crucial role of basic patches A and B in RPS19
function.
As already observed with this assay (23), among class I
mutations, I65P
Sc (L64P
Hs) was not viable, I15F
Sc
(V15F
Hs) strongly aﬀected RPS19 function, whereas
substitution A62S
Sc (A61S
Hs) had little impact on cell
growth, which was also the case for class II mutation
G121S
Sc (G120S
Hs). Although aﬀecting highly conserved
residues, these two latter mutations may have more critical
eﬀects in human than in yeast.
Requirement ofpatches A andB forRPS19incorporation
into pre-ribosomes
In order to further characterize the loss-of-function
associated with mutation of surface residues, we tested
whether class II mutations aﬀected RPS19 incorporation
into pre-ribosomes. We thus analysed association of
RPS19 mutants with pre-ribosomal RNAs in yeast. TAP
tagged wild-type and mutant alleles of RPS19A were
expressed in place of the endogenous RPS19A gene in a
rps19A/RPS19B
þ strain. Production of RPS19 in this
strain is insuﬃcient and pre-rRNA processing is partially
defective (5), which mimics RPS19 haploinsuﬃciency in
DBA patients. Using the complementation assay
described in Figure 3, we checked that the RPS19-TAP
protein remained functional (data not shown).
WT R57Q R57E R63E A62S R63W R63Q R102E R122E R102H G121S I15F I65P S60E _
GAL
GLC
Conserved Patch A (mutation hot spot) Conserved Patch B
Class II mutations Class I mutations
R130E-
R134E
Figure 3. Eﬀect of mutations on RPS19 function in yeast. Capacity of various RPS19 mutants to complement RPS19 expression knockdown was
tested in a yeast strain expressing wild-type RPS19 under control of a GAL promoter. Expression of wild-type RPS19 gene is shutdown upon
transfer to glucose containing medium whereas transcription of the mutant forms is driven by a constitutive promoter. Cells were spotted at three
diﬀerent densities.
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RPS19-TAP and the G121S
Sc mutant co-precipitated
with the 18S and 25S rRNAs (Figure 4b, lower panel),
indicating incorporation into mature ribosomes
(not dissociated under our experimental conditions).
Detection of the precursors of the 18S rRNA, by
northern blot analysis with the D-A2 probe, showed
co-precipitation of the 20S pre-rRNA (Figure 4a, upper
panel), the direct precursor to the 18S rRNA (Figure 4b).
This indicates the presence of these proteins in pre-40S
particles. The 32S and 35S pre-rRNAs, which are part of
the early 90S pre-ribosomes, were undetectable or close to
WT WT
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32S
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35S
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25S
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D
A0A1 A2A3 EC2C1 D
18S 25S 5.8S
5′ 3′
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A3 EC2
25S 5.8S
B C1
35S
A2A3 EC2 D
18S 25S 5.8S
C1 32S
27S-A 2 20S
(c)
(a)
(b)
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25S 5.8S
B C1 27S-A 3 A2 D
Pre-40S Pre-60S
90S pre-ribosomes
40S rib. subunit 60S rib. subunit
Pre-40S Pre-60S
rps19 − WT
60S rib. subunit No maturation
A0A1 A2A3 EC2C1 D
18S 25S 5.8S
5′ 3′
ITS1 ITS2 ETS1 ETS2
35S
A2A3 EC2 D
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Figure 4. Co-immunoprecipitation of precursor and mature ribosomal RNAs with RPS19-TAP. (a) Schematic of pre-rRNA processing in wild-type
(top panel) or rps19 deﬁcient cells (lower panel). Letters above pre-rRNAs indicate cleavage sites. (b, c) TAP-tagged wild-type or mutated RPS19A
expressed in rps19A/RPS19B yeast cells were isolated with IgG Sepharose beads. Pre-rRNAs in the whole cell extract (‘Input’) and the isolated
material (‘I.P.’) were analyzed by northern blot with probes complementary to segment D-A2 (panel B) or to segment A2-A3 (panel C). The mature
18S and 25S rRNAs were detected by ethidium bromide staining. The three panels correspond to independent experiments. In panels A and C,
expression of the sole TAP tag was used as a negative control (TAP). The precipitation background level was also evaluated by detecting the 27S-B
pre-rRNA with a probe complementary to the ITS2 (data not shown):50.1% was co-precipitated in panel A and C,50.3% in panel B, as measured
by phosphorimaging. The portion of co-precipitated 20S, 18S and 25S RNAs did not signiﬁcantly exceed the background value in all panels, except
for the wild-type and G121S forms (1–3% of co-precipitation). (d) Levels of TAP-tagged proteins in inputs (corresponding to panel A) were analyzed
by western blot with peroxidase anti-peroxidase antibody complexes, which bind to protein A.
5918 Nucleic Acids Research, 2007, Vol. 35, No. 17background in the precipitated fractions, depending on
the experiments.
Mutations in basic patch A (R57E
Sc, R57Q
Sc, R63E
Sc)
or basic patch B (R102E
Sc, R122E
Sc) reduced the
amount of co-precipitated mature 18S and 25S rRNAs
to background level (Figure 4b and c, lower panel).
A similar result was obtained with class I mutation I15F
Sc.
In addition, these proteins did not co-purify with 20S
pre-rRNA (Figure 4b). This result was not correlated with
diﬀerences in protein expression levels of the various
mutants (Figure 4d). Cleavage of the 32S pre-rRNA in the
early 90S pre-ribosomal particles normally yields the 20S
and 27S-A2 pre-rRNAs, included in the pre-40S and pre-
60S particles, respectively (Figure 4a, left panel).
Deﬁciency in RPS19 was shown to block cleavage at site
A2 (5); alternative cleavage at site A3 produces the 21S
and 27S-A3 pre-rRNAs, as illustrated in ﬁgure 4a
(right panel). We thus considered the hypothesis
that RPS19 mutants were incorporated into ill-matured
pre-40S particles containing 21S pre-rRNA instead of 20S.
As expected, a signiﬁcant increase in the amount of 21S
pre-rRNA, paralleled by a drop in the 27S-A2 pre-rRNA
level, was detected in cells expressing RPS19-TAP with
mutations R57E
Sc, R63E
Sc, R102E
Sc or R122E
Sc
R122E R102E R130E-R134E WT
R57Q R57E S60E R63E
A62S G121S WT I15F
WT
51 0 1 5 2 0
5 10 15 20 5 10 15 20 5 10 15 20 5 10 15 20
5 10 15 20 5 10 15 20 5 10 15 20 5 10 15 20
5 10 15 20 5 10 15 20 5 10 15 20 5 10 15 20
51 0 1 5 2 0
TAP
TOP BOTTOM FRACTIONS
OD 262 nm
RPS19
80S
POLYSOMES
Free 40S subunits
Free 60S subunits
(a)
(b)
(c)
Figure 5. Analysis of wild-type and mutant RPS19 association to ribosomes on sucrose gradient.Ribosomes from rps19A/RPS19B yeast strains
expressing wild-type or mutated forms of RPS19A fused to the TAP tag were separated on sucrose gradient as described in material and methods.
RPS19-TAP was detected in gradient fractions on slot blots with peroxidase. Panels a, b and c correspond to three series of experiments. Experiments
were performed two or three times with similar results. Expression of the sole TAP tag was used as a negative control (TAP).
Nucleic Acids Research, 2007, Vol. 35,No. 17 5919(Figure 4c, ‘input’). However, the 21S pre-rRNA did not
co-precipitate with mutated RPS19-TAP (Figure 4c,
‘I. P.’). Thus, mutation of the basic patches A and B
prevents incorporation of RPS19 into pre-ribosomal
particles.
These data were fully consistent with the analysis of
RPS19 association with ribosomes on sucrose gradients.
As shown in Figure 5a, the wild-type TAP-RPS19 protein
was mostly present in the fractions containing the
40S subunits, the 80S ribosomes and the polysomes,
indicating very eﬃcient incorporation into mature
subunits. In contrast, mutations in conserved patches A
and B resulted in a large amount of free protein at the top
of the gradient, with no preferential association
with mature ribosomes (Figure 5a,b). Noticeably, part of
these mutated forms of RPS19 was present in high-density
fractions. The A62S
Sc and G121S
Sc mutants, as well as
double mutant R130E
Sc/R134E
Sc (outside of the con-
served basic patches), which all support growth in RPS19
depleted yeast, showed an association proﬁle very close to
that of wild-type RPS19 (Figure 5c). The I15F
Sc mutation,
which does not totally abrogate RPS19 function in yeast,
showed partial association with mature ribosomes
(Figure 5c).
These results indicate that the solvent accessible
residues in the mutation hot spot (patch A) or in basic
patch B play a critical role in the incorporation of RPS19
into pre-ribosomes. This may involve direct
interaction with pre-ribosomal RNA, as supported by
the positive charge of these domains, and/or with
ribosomal proteins.
In conclusion, we propose that DBA missense muta-
tions primarily result in RPS19 haplodeﬁciency, by
impacting either its folding and its stability, or its capacity
to engage intermolecular interactions. The DBA mutation
hot spot appears as a key structural element of RPS19
involved both in the constitution of the hydrophobic core
and in a highly conserved surface. Impairment of
ribosome biogenesis resulting from RPS19 haplodeﬁciency
may have two direct consequences. First, a low rate of
small ribosomal subunit production may limit the cell
translation capacity (25). Second, alteration of ribosome
biogenesis, and subsequently of the nucleolus organization
(7), may be perceived by the cell as a ‘nucleolar stress’
and favor cell cycle arrest (27–29) These phenomena,
alone or in combination, could prevent diﬀerentiation of
pro-erythroblasts (7,12,30). In addition, our data do not
exclude a dominant negative eﬀect of the missense
mutants, upstream or aside of association with pre-
ribosomes, especially in the case of the more stable class
II mutants. Presence of some mutants in high-density
fractions of the sucrose gradient suggests that they may be
engaged in multi-molecular complexes, diﬀerent from
ribosomes, and whose composition remains to be deter-
mined. Establishing genotype/phenotype relationships has
proved diﬃcult in DBA and this remains true when
considering the relative clinical impacts of class I and class
II mutations. Availability of RPS19 crystal structure
should be decisive to design new strategies to understand
RPS19 function and its role in erythropoiesis.
PDB code: PDB coordinates and structure factors have
been deposited at the PDB under accession number 2v7f.
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